Avricore Health CEO and Special Guests Join Radius Research for Investor Update Pharmaceutical Investing
Medtronic announces FDA approval of spinal cord stimulation therapy for treating chronic pain resulting from diabetic peripheral neuropathy Medical Device Investing
Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Pharmaceutical Investing
Applied UV Continues to Expand Intellectual Portfolio with Additional Patent Grant Medical Device Investing
Bloom Health Partners Announces Contract With State of Texas For K-12 Schools Medical Device Investing
Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation Pharmaceutical Investing
Cloud DX Announces Voluntary Extension of Lock-up Agreements with Company Insiders Medical Device Investing